Sebastian Hoberück

523 total citations
33 papers, 278 citations indexed

About

Sebastian Hoberück is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sebastian Hoberück has authored 33 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Sebastian Hoberück's work include Prostate Cancer Treatment and Research (10 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Peptidase Inhibition and Analysis (5 papers). Sebastian Hoberück is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Peptidase Inhibition and Analysis (5 papers). Sebastian Hoberück collaborates with scholars based in Germany, United States and Italy. Sebastian Hoberück's co-authors include Jörg Kotzerke, Klaus Zöphel, Enrico Michler, Tobias Hölscher, Anja Braune, Johannes Notni, Wilko Weichert, Katja Steiger, Ivan Platzek and Steffen Löck and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Sebastian Hoberück

28 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sebastian Hoberück Germany 9 155 120 100 38 37 33 278
Grillo Ruggieri F Italy 11 118 0.8× 145 1.2× 123 1.2× 19 0.5× 81 2.2× 33 334
J. Luna Spain 10 59 0.4× 121 1.0× 101 1.0× 44 1.2× 36 1.0× 23 322
Eliza M. Raymundo United States 7 52 0.3× 129 1.1× 29 0.3× 22 0.6× 43 1.2× 14 251
Benjamin Noto Germany 9 182 1.2× 184 1.5× 65 0.7× 5 0.1× 51 1.4× 19 321
Shahin Shajahan United States 7 107 0.7× 129 1.1× 65 0.7× 4 0.1× 27 0.7× 9 316
Malik Juweid United States 8 196 1.3× 78 0.7× 76 0.8× 5 0.1× 47 1.3× 14 304
Esben Andreas Carlsen Denmark 9 116 0.7× 61 0.5× 277 2.8× 13 0.3× 19 0.5× 26 399
Khalid Jazieh United States 9 35 0.2× 102 0.8× 173 1.7× 8 0.2× 76 2.1× 24 285
Makiko Murota Japan 8 55 0.4× 165 1.4× 61 0.6× 4 0.1× 39 1.1× 25 307
A. Qin United States 8 88 0.6× 149 1.2× 208 2.1× 4 0.1× 24 0.6× 20 286

Countries citing papers authored by Sebastian Hoberück

Since Specialization
Citations

This map shows the geographic impact of Sebastian Hoberück's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Hoberück with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Hoberück more than expected).

Fields of papers citing papers by Sebastian Hoberück

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastian Hoberück. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Hoberück. The network helps show where Sebastian Hoberück may publish in the future.

Co-authorship network of co-authors of Sebastian Hoberück

This figure shows the co-authorship network connecting the top 25 collaborators of Sebastian Hoberück. A scholar is included among the top collaborators of Sebastian Hoberück based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastian Hoberück. Sebastian Hoberück is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fendler, Wolfgang P., Sebastian Hoberück, Isabel Rauscher, et al.. (2025). Prostate cancer risk groups by PSMA-PET PROMISE (PPP): Results from an international multi-center registry study.. Journal of Clinical Oncology. 43(5_suppl). 266–266. 1 indexed citations
3.
Miederer, Matthias, Marc Pretze, Andreas Hartig, et al.. (2025). Staging metastatic urothelial cancer with Nectin‐4 imaging using Gallium‐68‐ N188 PET / CT. British Journal of Urology. 137(1). 166–172. 2 indexed citations
5.
Fendler, Wolfgang P., Sebastian Hoberück, Isabel Rauscher, et al.. (2025). Updated prostate cancer risk groups by PSMA-PET PROMISE (PPP2): Results from an international multi-centre registry study.. Journal of Clinical Oncology. 43(16_suppl). 5045–5045. 1 indexed citations
7.
Kaiser, Daniel, Sebastian Hempel, Sebastian Hoberück, et al.. (2021). Spleno-aortic radiodensity ratio – A distinctive imaging feature to predict short-term outcome in critical care unit. European Journal of Radiology. 143. 109939–109939.
8.
Hoberück, Sebastian, Steffen Löck, Klaus Zöphel, et al.. (2020). [68Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study. EJNMMI Research. 10(1). 135–135. 15 indexed citations
10.
Heidrich, Felix M., et al.. (2020). Vascular changes of the superior mesenteric artery (SMA): A new component of the hypovolemic shock complex (HSC). European Journal of Radiology. 133. 109370–109370. 2 indexed citations
11.
Hoberück, Sebastian, et al.. (2020). Hepatic Vascular Malformation Mimics PSMA-Positive Prostate Cancer Metastasis. Clinical Nuclear Medicine. 45(6). e283–e284. 5 indexed citations
12.
Kaiser, Daniel, et al.. (2020). Bilateral adrenal enhancement revised—adrenal-to-spleen ratio as an appropriate mortality predictor. Abdominal Radiology. 46(5). 2107–2114. 4 indexed citations
13.
Kühn, Jens‐Peter, et al.. (2020). Adrenal glands enhancement in computed tomography as predictor of short-and intermediate term mortality in critically ill patients. Clinical Imaging. 70. 56–60. 4 indexed citations
14.
Hoberück, Sebastian, Gerd Wunderlich, Enrico Michler, et al.. (2019). Dual‐time‐point 64Cu‐PSMA‐617‐PET/CT in patients suffering from prostate cancer. Journal of Labelled Compounds and Radiopharmaceuticals. 62(8). 523–532. 24 indexed citations
15.
Michler, Enrico, Sebastian Hoberück, Filippo Martino, Ivan Platzek, & Jörg Kotzerke. (2019). Diagnosis of Huntington’s disease via sequential 18F-DOPA and 18F-FDG PET/MRI. Nuklearmedizin - NuclearMedicine. 58(5). 403–404.
16.
Kolb, Channa, Jens‐Peter Kühn, Uwe Speiser, et al.. (2019). Comparison of sequential and high-pitch-spiral coronary CT-angiography: image quality and radiation exposure. International journal of cardiac imaging. 35(7). 1379–1386. 7 indexed citations
17.
Hoberück, Sebastian, et al.. (2019). Diffusion-weighted MRI for initial staging in Hodgkin`s lymphoma: comparison with FDG PET. European Journal of Radiology. 123. 108775–108775. 1 indexed citations
18.
Hoberück, Sebastian, et al.. (2018). Fluorodeoxyglucose-positive Splenic Infarctions are Completely Regressive Just after 4 Months. Indian Journal of Nuclear Medicine. 33(3). 239–241. 1 indexed citations
19.
Hoberück, Sebastian, et al.. (2018). Unexpected Bone Metastases in 99mTc-Pertechnetate Scan of Recurrent Goiter. Clinical Nuclear Medicine. 44(1). 72–74. 2 indexed citations
20.
Hoberück, Sebastian, et al.. (2018). Prostate-Specific Membrane Antigen Expression in Distal Radius Fracture. Clinical Nuclear Medicine. 43(8). 611–613. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026